scispace - formally typeset
C

Chen Jin

Researcher at Peking Union Medical College

Publications -  45
Citations -  948

Chen Jin is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Mesenchymal stem cell & Percutaneous coronary intervention. The author has an hindex of 15, co-authored 33 publications receiving 580 citations.

Papers
More filters
Journal ArticleDOI

Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19

TL;DR: Exosomes obtained from ATV-pretreated MSCs have significantly enhanced therapeutic efficacy for treatment of AMI possibly through promoting endothelial cell function and mediates the cardioprotective roles of MSCATV-Exo in promoting angiogenesis.
Journal ArticleDOI

Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance

TL;DR: Combinatorial delivery of exosomes and stem cells in a sequential manner effectively reduces scar size and restores heart function after AMI and may represent as an alternative promising strategy for stem cell-based heart repair and therapy.
Journal ArticleDOI

Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway

TL;DR: Pretreatment with a single low loading dose of TXL 1 h before ischemia reduces myocardial no-reflow and is chemia-reperfusion injury by upregulating the phosphorylation of eNOS at Ser(1179) and Ser(635), and this effect is partially mediated by the PKA pathway.
Journal ArticleDOI

Induction of Autophagy by Tongxinluo Through the MEK/ERK Pathway Protects Human Cardiac Microvascular Endothelial Cells From Hypoxia/Reoxygenation Injury

TL;DR: Autophagy is a protective mechanism in CMECs subjected to I/R injury and TXL can promote autophagy through activation of the mitogen-activated protein kinase/ERK pathway, according to a dose-dependent manner.
Journal ArticleDOI

Atorvastatin treatment improves the effects of mesenchymal stem cell transplantation on acute myocardial infarction: The role of the RhoA/ROCK/ERK pathway

TL;DR: ATV improves the post-infarct microenvironment via RhoA/ROCK/ERK inhibition and thus facilitates the survival and efficacy of implanted MSCs and may be not responsible for the cardiac benefits that follow MSC transplantation.